Thymalin Guia & Tabela de Dose

What is Thymalin?

Thymalin is a polypeptide complex extracted from the thymus gland — a small organ sitting behind your breastbone that plays a starring role in training your immune system. Think of the thymus as a military academy for immune cells. Thymalin is essentially a concentrated signal from that academy, carrying instructions that help raw immune-cell recruits grow up into fully functional soldiers.^[1]

It belongs to a class of compounds called peptide bioregulators — short chains of amino acids that researchers believe can nudge specific tissues back toward normal function. Thymalin has been studied for decades, primarily in Russia and Eastern Europe, as a tool for restoring immune balance, especially in older adults and people with immune dysfunction.^[4]

Important note: Thymalin is a research compound only. Nothing on this page is medical advice, and Thymalin is not approved for human therapeutic use in most countries.

How Thymalin Works

Here is a simple way to picture it. Your bone marrow constantly produces hematopoietic stem cells — blank-slate cells that can become many different blood and immune cell types. To become a mature T lymphocyte (a key virus-fighting immune cell), those blank-slate cells need the right signals. Thymalin appears to be one of those signals.

In laboratory studies, Thymalin reduced the activity of early stem-cell markers (CD44 and CD117) by two to three times and boosted the marker for mature T lymphocytes (CD28) by nearly seven times. Researchers interpret this as evidence that Thymalin pushes stem cells to finish their education and become fully armed T cells.^[1]

Thymalin contains two active dipeptides — short two-amino-acid fragments called KE and EW. Lab work shows that KE stimulates cellular immunity and activates macrophages, lymphocytes, and neutrophils, while EW appears to dial down inflammatory signals linked to cytokine storms — the dangerous over-reaction of the immune system seen in severe respiratory illness.^[3] Specifically, in cell culture experiments, Thymalin and its dipeptides reduced levels of the inflammatory cytokines IL-1β, IL-6, and TNF-α by 1.4 to 6 times.^[3]

What the Research Shows

Most of the published research on Thymalin comes from the St. Petersburg Institute of Bioregulation and Gerontology. Here is a plain-language summary of the key findings:

• Stem cell differentiation: A 2020 cell-culture study found that Thymalin strongly promoted the maturation of human hematopoietic stem cells into CD28+ T lymphocytes — the same immune cells that become depleted in severe COVID-19.^[1]
• Long-term aging study: A six-to-eight-year clinical observation involving 266 elderly participants found that Thymalin-treated patients experienced roughly a 2-fold drop in acute respiratory illness, reduced rates of heart disease and hypertension, and a 2.0–2.1-fold lower mortality rate compared to controls. When Thymalin was combined with the pineal peptide Epithalamin annually for six years, researchers recorded a 4.1-fold decrease in mortality versus control.^[2]
• COVID-19 inflammation model: A 2023 molecular and in-vitro study mapped out how Thymalin's KE and EW dipeptides interact with DNA sequences linked to cytokine-storm genes, and confirmed in cell culture that these peptides meaningfully reduced key inflammatory proteins.^[3]
• Bone repair: A 2024 animal study in rats found that injecting thymalin around a mandible (jawbone) defect accelerated cleanup of dead tissue, improved immune-cell activity at the repair site, and enhanced bone regeneration when combined with a hydroxyapatite graft material.^[5]
• Tumor and thymus interactions: Research has also explored Thymalin's role in activation therapy alongside antitumor models, examining effects on both tumor tissue and thymus function in animal subjects.^[6]

What Thymalin Is Being Studied For

• Immune restoration and immunomodulation in aging populations^[2]
• T lymphocyte differentiation and antiviral immune support^[1]
• Inflammatory cytokine regulation, including cytokine-storm models^[3]
• Tissue repair and reparative osteogenesis^[5]
• Geroprotection — slowing age-related functional decline^[4]
• Oncology-adjacent immune research^[6]

How Thymalin Is Dosed in Research

Dosing in published research varies depending on the model and the outcome being studied. The dosage chart on this page summarizes the ranges used in immunomodulation and immune dysfunction correction research. You can also use the calculator on this page to work out volumes based on your reconstitution concentration. Always refer to the primary literature and a qualified researcher before applying any dosing protocol.

Mixing and Storing Thymalin

Thymalin in research settings is typically supplied as a lyophilized (freeze-dried) powder in a sealed vial. To reconstitute it, researchers add bacteriostatic water or sterile saline slowly down the side of the vial — never shake it, as this can break down the peptide chains. Gently swirl until the powder fully dissolves. Once reconstituted, store the vial in a refrigerator (2–8 °C / 36–46 °F), keep it away from light, and use it within the timeframe recommended by the supplier — typically two to four weeks. Unmixed powder, kept sealed and away from moisture and heat, can remain stable for considerably longer. Always label vials with the date of reconstitution.

Sources

1. Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells. — Bulletin of experimental biology and medicine, 2020. PMID 33237528.
2. [Geroprotective effect of thymalin and epithalamin]. — Advances in gerontology = Uspekhi gerontologii, 2002. PMID 12577695.
3. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. — International journal of molecular sciences, 2023. PMID 37686182.
4. Peptides and Ageing. — Neuro endocrinology letters, 2002. PMID 12374906.
5. Reparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study. — Wiadomosci lekarskie (Warsaw, Poland : 1960), 2024. PMID 38431810.
6. Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo. — Bulletin of experimental biology and medicine, 2018. PMID 29797130.